Combining hepatitis B core‐related and surface antigens at end of nucleos(t)ide analogue treatment to predict off‐therapy relapse risk

2018101 citationsJournal Article

Authors

Yao‐Chun Hsu · Fu Jen Catholic University

Mindie H. Nguyen · Stanford Medicine

Lein‐Ray Mo · Tainan Municipal Hospital

Ming‐Shiang Wu · National Taiwan University Hospital

Tzeng‐Huey Yang · Luodong Poh-Ai Hospital

Chieh‐Chang Chen · National Taiwan University Hospital

Cheng‐Hao Tseng

Abstract

Serum HBcrAg and HBsAg levels were independent predictors of off-NA relapse and can be factored into a risk score to guide treatment cessation in patients with CHB.

Topics & Keywords

Hepatitis B Virus Studies Hepatitis C virus research Liver Disease Diagnosis and Treatment

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Alimentary Pharmacology & Therapeutics

Volume 49, Issue 1, pp. 107-115

DOI: 10.1111/apt.15058

Field-Weighted Citation Impact: 7.78

Command Palette